Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：111 Table Number：132
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Over-The-Counter (OTC) Drugs market in this environment. In terms of revenue, this research report indicated that the global Over-The-Counter (OTC) Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Over-The-Counter (OTC) Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ?Bayer aims at producing XX Over-The-Counter (OTC) Drugs in 2020, with XX % production to take place in global market, ????Boehringer Ingelheim accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Over-The-Counter (OTC) Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Over-The-Counter (OTC) Drugs Market? Bayer Boehringer Ingelheim GSK Novartis Pfizer PGT healthcare Sanofi Teva Pharmaceuticals Takeda Cipla Sun Pharmaceutical Industries Glenmark Innovus Pharmaceuticals ... Major Type of Over-The-Counter (OTC) Drugs Covered in XYZResearch report: Cold and Flu Products Analgesics Dermatological Products Gastrointestinal Products Vitamin Other Application Segments Covered in XYZResearch Market Hospital Pharmacy Retail Pharmacy Online Pharmacy For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Over-The-Counter (OTC) Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Cold and Flu Products -Product Introduction and Major Manufacturers 1.1.2 Analgesics -Product Introduction and Major Manufacturers 1.1.3 Dermatological Products -Product Introduction and Major Manufacturers 1.1.4 Gastrointestinal Products -Product Introduction and Major Manufacturers 1.1.5 Vitamin -Product Introduction and Major Manufacturers 1.1.6 Other -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Over-The-Counter (OTC) Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Over-The-Counter (OTC) Drugs Market 3.1.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Over-The-Counter (OTC) Drugs Market 3.2.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Over-The-Counter (OTC) Drugs Market 3.3.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Over-The-Counter (OTC) Drugs Market 3.4.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Over-The-Counter (OTC) Drugs Market 3.5.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Over-The-Counter (OTC) Drugs Market 3.6.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Over-The-Counter (OTC) Drugs Market 3.7.1 Top Companies leading Over-The-Counter (OTC) Drugs Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Over-The-Counter (OTC) Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Over-The-Counter (OTC) Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Over-The-Counter (OTC) Drugs Sales and Growth Rate (2021-2026) 5.2 Global Over-The-Counter (OTC) Drugs Sales Value and Growth Rate (2021-2026) 6 Over-The-Counter (OTC) Drugs Competitive Analysis 6.1 Bayer 6.1.1 Bayer Company Profiles 6.1.2 Bayer Product Introduction 6.1.3 Bayer Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Boehringer Ingelheim 6.2.1 Boehringer Ingelheim Company Profiles 6.2.2 Boehringer Ingelheim Product Introduction 6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 GSK 6.3.1 GSK Company Profiles 6.3.2 GSK Product Introduction 6.3.3 GSK Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Novartis 6.4.1 Novartis Company Profiles 6.4.2 Novartis Product Introduction 6.4.3 Novartis Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Pfizer 6.5.1 Pfizer Company Profiles 6.5.2 Pfizer Product Introduction 6.5.3 Pfizer Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 PGT healthcare 6.6.1 PGT healthcare Company Profiles 6.6.2 PGT healthcare Product Introduction 6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Sanofi 6.7.1 Sanofi Company Profiles 6.7.2 Sanofi Product Introduction 6.7.3 Sanofi Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Teva Pharmaceuticals 6.8.1 Teva Pharmaceuticals Company Profiles 6.8.2 Teva Pharmaceuticals Product Introduction 6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Takeda 6.9.1 Takeda Company Profiles 6.9.2 Takeda Product Introduction 6.9.3 Takeda Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Cipla 6.10.1 Cipla Company Profiles 6.10.2 Cipla Product Introduction 6.10.3 Cipla Over-The-Counter (OTC) Drugs Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Sun Pharmaceutical Industries 6.12 Glenmark 6.13 Innovus Pharmaceuticals 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Over-The-Counter (OTC) Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Over-The-Counter (OTC) Drugs Sales (K Unit) by Type (2015-2026) Figure Global Over-The-Counter (OTC) Drugs Sales (K Unit) and Growth Rate (2015-2026) Figure Global Over-The-Counter (OTC) Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Over-The-Counter (OTC) Drugs Sales Value (Million USD) by Type (2015-2026) Figure Global Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Over-The-Counter (OTC) Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Over-The-Counter (OTC) Drugs Sales (K Unit) by Application (2015-2026) Table China Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table China Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table China Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure China Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table China Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table China Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table China Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure China Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table EU Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table EU Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table EU Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure EU Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table EU Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table EU Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure EU Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table USA Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table USA Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table USA Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure USA Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table USA Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table USA Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure USA Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table Japan Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table Japan Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table Japan Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table Japan Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure Japan Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table India Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table India Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table India Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure India Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table India Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table India Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table India Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure India Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table Southeast Asia Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table Southeast Asia Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table Southeast Asia Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure Southeast Asia Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Table South America Over-The-Counter (OTC) Drugs Sales (K Unit) of Major Company (2015-2020) Table South America Over-The-Counter (OTC) Drugs Sales Market Share of Major Company (2015-2020) Table South America Over-The-Counter (OTC) Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure South America Over-The-Counter (OTC) Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Over-The-Counter (OTC) Drugs Sales Value Share of Major Company (2015-2020) Table South America Over-The-Counter (OTC) Drugs Price (USD/Unit), by Type (2019-2020) Table South America Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure South America Over-The-Counter (OTC) Drugs Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Over-The-Counter (OTC) Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Over-The-Counter (OTC) Drugs Figure Cost Structure of Over-The-Counter (OTC) Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Over-The-Counter (OTC) Drugs Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Over-The-Counter (OTC) Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ?Bayer Profiles Table ?Bayer Over-The-Counter (OTC) Drugs Product Introduction Table ?Bayer Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ?Bayer SWOT Analysis Table ????Boehringer Ingelheim Profiles Table ????Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Introduction Table ????Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Boehringer Ingelheim SWOT Analysis Table ????GSK Profiles Table ????GSK Over-The-Counter (OTC) Drugs Product Introduction Table ????GSK Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????GSK SWOT Analysis Table ????Novartis Profiles Table ????Novartis Over-The-Counter (OTC) Drugs Product Introduction Table ????Novartis Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Novartis SWOT Analysis Table ????Pfizer Profiles Table ????Pfizer Over-The-Counter (OTC) Drugs Product Introduction Table ????Pfizer Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Pfizer SWOT Analysis Table ????PGT healthcare Profiles Table ????PGT healthcare Over-The-Counter (OTC) Drugs Product Introduction Table ????PGT healthcare Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????PGT healthcare SWOT Analysis Table ????Sanofi Profiles Table ????Sanofi Over-The-Counter (OTC) Drugs Product Introduction Table ????Sanofi Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Sanofi SWOT Analysis Table ????Teva Pharmaceuticals Profiles Table ????Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Introduction Table ????Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Teva Pharmaceuticals SWOT Analysis Table ????Takeda Profiles Table ????Takeda Over-The-Counter (OTC) Drugs Product Introduction Table ????Takeda Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Takeda SWOT Analysis Table ????Cipla Profiles Table ????Cipla Over-The-Counter (OTC) Drugs Product Introduction Table ????Cipla Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Cipla SWOT Analysis Table ????Sun Pharmaceutical Industries Profiles Table ????Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Introduction Table ????Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Sun Pharmaceutical Industries SWOT Analysis Table ????Glenmark Profiles Table ????Glenmark Over-The-Counter (OTC) Drugs Product Introduction Table ????Glenmark Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Glenmark SWOT Analysis Table ????Innovus Pharmaceuticals Profiles Table ????Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Introduction Table ????Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
